 | | PRD_001021 | | Name: | INHIBITOR ARC-670 | | Formula: | C53 H103 N31 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001022 | | Name: | (2S,5S,8S,13S,16Z)-5-benzyl-2-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxylic acid | | Formula: | C36 H46 N8 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001023 | | Name: | (2S,5S,8S,13S,16Z)-5-(cyclohexylmethyl)-3,6,9,15,18-pentaoxo-2-(3-phenylprop-2-en-1-yl)-8-{3-[(pyrazin-2-ylcarbonyl)amino]propyl}-1,4,7,10,14-pentaazacyclooctadec-16-ene-13-carboxamide | | Formula: | C38 H49 N9 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001025 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H107 N18 O19 S2 | | Definition date: | 2013-10-09 | | Last modified: | 2023-11-03 |
|
 | | PRD_001031 | | Name: | Microcystin-LR (MCLR) bound form | | Formula: | C49 H77 N10 O12 | | Definition date: | 2013-05-08 | | Last modified: | 2023-11-03 |
|
 | | PRD_001041 | | Name: | TMC-95A mimic ligand yCP:4e | | Formula: | C61 H83 N9 O10 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001044 | | Name: | TMC-95A mimic ligand yCP:3a | | Formula: | C60 H80 N8 O11 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001047 | | Name: | (2E,4E)-N-[(2R,3S)-1-{[(5S,8S,9E)-2,7-dioxo-5-(propan-2-yl)-1,6-diazacyclododec-9-en-8-yl]amino}-3-hydroxy-1-oxobutan-2-yl]dodeca-2,4-dienamide | | Formula: | C29 H48 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001049 | | Name: | TMC-95A mimic ligand yCP:4a chain Q | | Formula: | C55 H72 N8 O9 | | Definition date: | 2013-05-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_001064 | | Name: | N-(tert-butylcarbamoyl)-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]-L-prolinamide | | Formula: | C38 H47 N5 O7 | | Definition date: | 2014-03-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_001066 | | Name: | Muramyl tetrapeptide | | Formula: | C30 H53 N8 O13 | | Definition date: | 2014-03-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001069 | | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | | Formula: | C16 H28 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000291 | | Name: | BETA-SECRETASE INHIBITOR NVP-AUR200 | | Formula: | C34 H61 N5 O7 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001071 | | Name: | N~4~-(2,2-dimethylpropyl)-N~1~-{(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-aspartamide | | Formula: | C32 H41 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000292 | | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | | Formula: | C29 H50 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001075 | | Name: | N-[(2S)-3-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-1-({(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}amino)-1-oxopropan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | | Formula: | C32 H38 N6 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000330 | | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | | Formula: | C30 H41 N5 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000332 | | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | | Formula: | C36 H46 N6 O13 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001107 | | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | | Formula: | C95 H147 N32 O21 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001125 | | Name: | Peptide ligand | | Formula: | C51 H75 N9 O14 | | Definition date: | 2013-12-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001157 | | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | | Formula: | C51 H69 N10 O11 | | Definition date: | 2014-01-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_000377 | | Name: | N-(sulfanylacetyl)-D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide | | Formula: | C23 H36 Cl N6 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000387 | | Name: | N-(tert-butoxycarbonyl)-L-alanyl-L-alanyl-N-{(1R)-1-[(S)-[(1S)-2-{[(1R)-1-carboxyethyl]amino}-1-methyl-2-oxoethoxy](hydroxy)phosphoryl]-2-methylpropyl}-L-prolinamide | | Formula: | C26 H46 N5 O11 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000395 | | Name: | ACE-HAC-ARG-MAA-HAQ-SEL | | Formula: | C37 H58 N9 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001184 | | Name: | Dimethyl FK228 | | Formula: | C26 H42 N4 O6 S2 | | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | | Definition date: | 2014-03-05 | | Last modified: | 2023-11-03 |
|
